• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012.
CONCLUSIONS: Early and targeted therapy for high-risk individuals should be used to guide management of TTP patients for improved survival outcomes. PMID: 27079482 [PubMed - as supplied by publisher]
Source: Transfusion - April 14, 2016 Category: Hematology Authors: Goel R, King KE, Takemoto CM, Ness PM, Tobian AA Tags: Transfusion Source Type: research

Hospital discharge hemoglobin values and posthospitalization clinical outcomes in transfused patients undergoing noncardiac surgery.
CONCLUSION: Hospital discharge hemoglobin values for transfused surgical patients were not associated with hospital readmission rates except for those receiving postoperative intensive care. Further evaluation is warranted to understand downstream consequences of postsurgical anemia. PMID: 32794229 [PubMed - as supplied by publisher]
Source: Transfusion - August 12, 2020 Category: Hematology Authors: Kerfeld MJ, Kor DJ, Frank RD, Hanson AC, Passe MA, Warner MA Tags: Transfusion Source Type: research

A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
CONCLUSION: Two 750-mg FCM infusions are safe and superior to oral iron in increasing Hb levels in IDA patients with inadequate oral iron response. PMID: 23772856 [PubMed - as supplied by publisher]
Source: Transfusion - June 17, 2013 Category: Hematology Authors: Onken JE, Bregman DB, Harrington RA, Morris D, Acs P, Akright B, Barish C, Bhaskar BS, Smith-Nguyen GN, Butcher A, Koch TA, Goodnough LT Tags: Transfusion Source Type: research

Tolerance of intraoperative hemoglobin decrease during cardiac surgery.
CONCLUSIONS: Our findings show that a decrease of at least 50% from baseline Hb during cardiac surgery is associated with adverse outcomes, even if the absolute Hb level remains higher than the commonly used transfusion threshold of 7.0 g/dL. PMID: 24724943 [PubMed - as supplied by publisher]
Source: Transfusion - April 14, 2014 Category: Hematology Authors: Hogervorst E, Rosseel P, van der Bom J, Bentala M, Brand A, van der Meer N, van de Watering L Tags: Transfusion Source Type: research

Outcome of Jehovah's Witnesses after adult cardiac surgery: systematic review and meta-analysis of comparative studies.
CONCLUSION: JWs undergoing adult cardiac surgery have a nonsignificant trend toward better early outcome than controls receiving or not blood transfusions. The suboptimal quality of available studies prevents conclusive results on the possible benefits of a transfusion-free strategy in patients not refusing blood transfusion. PMID: 27197962 [PubMed - as supplied by publisher]
Source: Transfusion - May 19, 2016 Category: Hematology Authors: Vasques F, Kinnunen EM, Pol M, Mariscalco G, Onorati F, Biancari F Tags: Transfusion Source Type: research

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals.
CONCLUSION: Implementation of a unique, jurisdiction-wide PBM program was associated with improved patient outcomes, reduced blood product utilization, and product-related cost savings. PMID: 28150313 [PubMed - as supplied by publisher]
Source: Transfusion - February 1, 2017 Category: Hematology Authors: Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL Tags: Transfusion Source Type: research

A rationale for universal tranexamic acid in major joint arthroplasty: overall efficacy and impact of risk factors for transfusion.
CONCLUSIONS: Universal TXA was associated with a reduction of RBC transfusion, overall and in clinically relevant subgroups, strengthening the rationale for universal therapy. PMID: 30383292 [PubMed - as supplied by publisher]
Source: Transfusion - November 1, 2018 Category: Hematology Authors: Pavenski K, Ward SE, Hare GMT, Freedman J, Pulendrarajah R, Pirani RA, Sheppard N, Vance C, White A, Lo N, Waddell JP, Ho A, Schemitsch EH, Kataoka M, Bogoch ER, Saini K, David Mazer C, Baker JE Tags: Transfusion Source Type: research

Additional filtering of blood from a cell salvage device is not likely to show important additional benefits in outcome in cardiac surgery.
CONCLUSION: The routine use of an additional filter for transfusion of salvaged blood is unlikely to show important additional benefits. PMID: 30610759 [PubMed - as supplied by publisher]
Source: Transfusion - January 4, 2019 Category: Hematology Authors: de Vries AJ, Vermeijden WJ, van Pelt LJ, van den Heuvel ER, van Oeveren W Tags: Transfusion Source Type: research